BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 11046072)

  • 1. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
    Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
    J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig.
    Brady GF; Congdon KL; Clark AG; Sackey FN; Rudolph EH; Radic MZ; Foster MH
    J Immunol; 2004 May; 172(9):5313-21. PubMed ID: 15100270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens.
    Liu S; Velez MG; Humann J; Rowland S; Conrad FJ; Halverson R; Torres RM; Pelanda R
    J Immunol; 2005 Oct; 175(8):5067-76. PubMed ID: 16210610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ig light chain receptor editing in anergic B cells.
    Tze LE; Baness EA; Hippen KL; Behrens TW
    J Immunol; 2000 Dec; 165(12):6796-802. PubMed ID: 11120801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.
    Yachimovich N; Mostoslavsky G; Yarkoni Y; Verbovetski I; Eilat D
    Eur J Immunol; 2002 Apr; 32(4):1164-74. PubMed ID: 11932924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells.
    Zhang AH; Li X; Onabajo OO; Su Y; Skupsky J; Thomas JW; Scott DW
    J Autoimmun; 2010 Sep; 35(2):107-13. PubMed ID: 20579844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.
    Krishnamoorthy G; Lassmann H; Wekerle H; Holz A
    J Clin Invest; 2006 Sep; 116(9):2385-92. PubMed ID: 16955140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors.
    Kenny JJ; Rezanka LJ; Lustig A; Fischer RT; Yoder J; Marshall S; Longo DL
    J Immunol; 2000 Apr; 164(8):4111-9. PubMed ID: 10754305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype.
    Heltemes-Harris L; Liu X; Manser T
    J Immunol; 2004 Jan; 172(2):823-33. PubMed ID: 14707052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.
    Bettelli E; Baeten D; Jäger A; Sobel RA; Kuchroo VK
    J Clin Invest; 2006 Sep; 116(9):2393-402. PubMed ID: 16955141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance.
    Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW
    J Immunol; 2005 Jul; 175(2):909-16. PubMed ID: 16002689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.
    Pöllinger B; Krishnamoorthy G; Berer K; Lassmann H; Bösl MR; Dunn R; Domingues HS; Holz A; Kurschus FC; Wekerle H
    J Exp Med; 2009 Jun; 206(6):1303-16. PubMed ID: 19487416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice.
    Litzenburger T; Fässler R; Bauer J; Lassmann H; Linington C; Wekerle H; Iglesias A
    J Exp Med; 1998 Jul; 188(1):169-80. PubMed ID: 9653093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific depletion of autoreactive B lymphocytes by a recombinant fusion protein in vitro and in vivo.
    Zocher M; Baeuerle PA; Dreier T; Iglesias A
    Int Immunol; 2003 Jul; 15(7):789-96. PubMed ID: 12807817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis.
    von Büdingen HC; Menge T; Hauser SL; Genain CP
    Immunogenetics; 2006 Apr; 58(2-3):122-8. PubMed ID: 16528499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of mu heavy chain in B cell development. I. Blocked B cell maturation but complete allelic exclusion in the absence of Ig alpha/beta.
    Cronin FE; Jiang M; Abbas AK; Grupp SA
    J Immunol; 1998 Jul; 161(1):252-9. PubMed ID: 9647231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of receptor editing to the antibody repertoire.
    Casellas R; Shih TA; Kleinewietfeld M; Rakonjac J; Nemazee D; Rajewsky K; Nussenzweig MC
    Science; 2001 Feb; 291(5508):1541-4. PubMed ID: 11222858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of autoreactive myelin oligodendrocyte glycoprotein (MOG)-specific T cell repertoires in MOG-expressing mice.
    Fazilleau N; Delarasse C; Sweenie CH; Anderton SM; Fillatreau S; Lemonnier FA; Pham-Dinh D; Kanellopoulos JM
    Eur J Immunol; 2006 Mar; 36(3):533-43. PubMed ID: 16506290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.